The Analyst

May 16, 2022
How harmful is home country bias?
Stephen Clapham assesses the dangers for investors of sticking too close to familar territory
May 12, 2022
Hydrogen – brave new world or a pipedream?
Former City analyst Robin Hardy concludes his examination of the hydrogen sector by casting his net worldwide
May 05, 2022
Airlines' valuable lesson
The real headwind for airlines is not Covid, oil prices or oversupply says Stephen Clapham, and the issue applies to other companies too
April 26, 2022
ITM Power – lighter than air?
Former City analyst Robin Hardy runs the rule over ITM Power's potential for profiting from the growth of hydrogen as a fuel
April 12, 2022
Ceres: Fuelling doubts or full steam ahead?
Robin Hardy examines the prospects – and potential pitfalls – for a company seeking a piece of the green energy revolution
March 15, 2022
Where next for technology stocks?
After leading the bull market for years, technology stocks have sold off heavily. Former City analyst Robin Hardy examines what investors should do
March 03, 2022
Hipgnosis Song Fund – You can’t always get what you want
Going for a song or out of tune? Robin Hardy runs his slide rule over Hipgnosis Song Fund
February 17, 2022
Gamma Communications – XaaSperating?
Is Gamma Communications still a high-growth stock, or has the pandemic simply brought forward expected future demand? Former City analyst Robin Hardy takes a closer look
January 31, 2022
What we can learn from insiders' buying and selling
Stephen Clapham outlines some unheralded ways to study directors’ dealings
January 25, 2022
Euromoney Institutional Investor – look forwards not back
Business information is a valuable game to be in, but is Euromoney match fit for the future? Former City analyst Robin Hardy gives his verdict

1
...
6
7
8
9
10
11
12
...

Load More Articles